Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.
Bissell
Mina J
MJ
Le Beyec
Johanne
J
Anderson
Robin L
RL
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000517:prevention & control / Q000556:secondary*; D004195:Disease Models, Animal; D006801:Humans; D008297:Male; D061965:Matrix Metalloproteinase Inhibitors; D009362:Neoplasm Metastasis / Q000517:prevention & control; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*; D013876:Thiophenes / Q000627:therapeutic use
D000970:Antineoplastic Agents; D061965:Matrix Metalloproteinase Inhibitors; D013876:Thiophenes; D010649:Phenylalanine; C080985:batimastat